Cargando…
Intralipid therapy and adverse reproductive outcome: is there any evidence?
Controversy exists regarding the benefits of intravenous intralipid therapy in patients with a poor reproductive history. It is frequently reported that there is no evidence to support the effectiveness, utility or safety for this treatment. While individual studies may be perceived as weak, a syste...
Autores principales: | Kumar, Parijot, Marron, Kevin, Harrity, Conor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788620/ https://www.ncbi.nlm.nih.gov/pubmed/35118388 http://dx.doi.org/10.1530/RAF-20-0052 |
Ejemplares similares
-
Potential utility of a non-invasive menstrual blood immunophenotype analysis in reproductive medicine
por: Marron, Kevin, et al.
Publicado: (2022) -
Anti-oxidant mediated normalisation of raised intracellular cytokines in patients with reproductive failure
por: Marron, Kevin, et al.
Publicado: (2018) -
ART implantation failure and miscarriage in patients with elevated intracellular cytokine ratios: response to immune support therapy
por: Harrity, Conor, et al.
Publicado: (2018) -
Synthesis of middle–long–middle structured intralipids by biological catalysis and the evaluation of intralipids’ protective effect on liver injury rats
por: Liu, Changsheng, et al.
Publicado: (2021) -
Impacts of Intralipid on Nanodrug Abraxane Therapy and on the Innate Immune System
por: Chen, Yen-Ju, et al.
Publicado: (2020)